Examples of using Combination with trastuzumab in English and their translations into Slovak
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Perjeta in combination with trastuzumab and docetaxel.
Patients treated with docetaxel in combination with trastuzumab.
Pacientov liečených docetaxel v kombinácii s trastuzumabom.Patients treated with docetaxel in combination with trastuzumab.
Pacientov liečených docetaxelom v kombinácii s trastuzumabom.TAXOTERE 100 mg/ m² in combination with trastuzumab.
TAXOTERE 100 mg/ m² v kombinácii s trastuzumabom.Docetaxel 100 mg/m² in combination with trastuzumab.
Docefrez 100 mg/mm v kombinácii s trastuzumabom.Docetaxel 100 mg/m² in combination with trastuzumab.
Docetaxel 100 mg/mm v kombinácii s trastuzumabom.Docetaxel Winthrop 100 mg/ m² in combination with trastuzumab.
Docetaxel Winthrop 100 mg/ m² v kombinácii s trastuzumabom.No additional adverse reactions were reported to be associated with lapatinib in combination with trastuzumab.
Hlásené neboli žiadne ďalšie nežiaduce reakcie, ktoré by súviseli Lapatinib is also used in combination with trastuzumab for patients whose cancer is growing while receiving trastuzumab. .
Lapatinib sa používa aj v kombinácii s trastuzumabom pre pacientov, ktorých nádor rastie napriek liečbe Cohort B- 4 cycles of FEC followed by 4 cycles of Perjeta in combination with trastuzumab and docetaxel.
Kohorta B- 4 cykly FEC, po ktorých nasledovali 4 cykly Perjety v kombinácii s trastuzumabom a docetaxelom.When patients are candidates for treatment with docetaxel in combination with trastuzumab, they should undergo baseline cardiac assessment.
Pacientky, ktoré sú kandidátkami na liečbu docetaxelom v kombinácii s trastuzumabom, sa majú podrobiť základnému kardiologickému vyšetreniu.In combination with trastuzumab the recommended dose of docetaxel is 100 mg/m2 every three weeks, with trastuzumab administered weekly.
V kombinácii s trastuzumabom sa odporúča dávka 100 mg/m2 docetaxelu každé 3 týždne, trastuzumab sa podáva týždenne.In combination with trastuzumab the recommended dose of docetaxel is 100 mg/m2 every three weeks,
V kombinácii s trastuzumabom sa odporúča dávka 100 mg/ m2 docetaxelu podaná raz za tri týždne,The efficacy and safety of lapatinib in combination with trastuzumab in metastatic breast cancer were evaluated in a randomised trial.
Účinnosť a bezpečnosť lapatinibu v kombinácii s trastuzumabom pri metastatickom karcinóme prsníka boli hodnotené v randomizovanom skúšaní.Heart failure has been observed in patients receiving docetaxel in combination with trastuzumab, particularly following anthracycline(doxorubicin or epirubicin)-containing chemotherapy.
U pacientok liečených docetaxelom v kombinácii s trastuzumabom sa pozorovalo zlyhanie srdca, najmä po chemoterapii obsahujúcej antracyklíny(doxorubicín alebo epirubicín).In combination with trastuzumab for patients with hormone receptor-negative metastatic disease that has progressed on prior trastuzumab therapy(ies)
V kombinácii s trastuzumabom pre pacientov cyclophosphamide followed by 4 cycles of Perjeta in combination with trastuzumab and paclitaxel.
cyklofosfamidu podávaných každé dva týždne, po ktorých nasledovali 4 cykly Perjety v kombinácii s trastuzumabom.LVEF decreases were reported in 6.7% of patients who received lapatinib in combination with trastuzumab, as compared to 2.1% of patients who received lapatinib alone.
Zníženie EFĽK bolo hlásené u 6,7% pacientov, ktorí užívali lapatinib v kombinácii s trastuzumabom v porovnaní An increased incidence of LVEF declines was also observed in patients treated with Perjeta in combination with trastuzumab and docetaxel; LVEF recovered to≥50% in all patients.
Zvýšená incidencia poklesov LVEF sa pozorovala aj u pacientov liečených Perjetou v kombinácii s trastuzumabom a docetaxelom; LVEF sa obnovila na ≥ 50% u všetkých pacientov.Tyverb is prescribed in combination with trastuzumab, for patients who have hormone receptor- negative metastatic breast cancer
Tyverb sa predpisuje v kombinácii s trastuzumabom pre pacientov, ktorí majú metastatickú rakovinu prsníka 
